Is schizophrenia more common in men than in women? Does it usually start around a certain age? And do things like your race or location raise your chances of getting it? The field of epidemiology can ...
Brazilian researchers have developed a low-cost, portable biosensor that can quickly identify a protein whose altered levels ...
Neurocognitive dysfunction is common in offspring with a familial high risk for schizophrenia or bipolar disorder. FHR-SZ offspring show more severe, generalized impairment.
The symptoms of schizophrenia vary greatly from person to person. A new study shows how these differences manifest themselves in the structure of the brain. The symptoms of schizophrenia vary greatly ...
On Thursday, the FDA approved Bristol Myers Squibb & Co’s (NYSE:BMY) Cobenfy (xanomeline and trospium chloride, KarXT), an oral medication for schizophrenia in adults. Bristol-Myers added the ...
O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming to STAT, she worked at WNYC’s Radiolab and Scientific American, and her ...
Last month, Maryland Health Secretary Dr. Laura Herrera Scott shut down a first-of-its-kind inpatient study that’s shown promise for treating schizophrenia. On behalf of the patients who volunteered ...
People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug. Studies showed ...
CT-155 (Boehringer Ingelheim and Click Therapeutics), an investigational prescription digital therapeutic, was both safe and effective in reducing negative symptoms of schizophrenia in a new phase 3 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback